Effects of cilostazol in the heart

Cilostazol is a selective phosphodiesterase 3 (PDE3) inhibitor approved by the Food and Drug Administration for treatment of intermittent claudication. It has also been used in bradyarrhythmic patients to increase heart rates. Recently, cilostazol has been shown to prevent ventricular fibrillation i...

Full description

Saved in:
Bibliographic Details
Main Authors: Kanlop N., Chattipakorn S., Chattipakorn N.
Format: Review
Language:English
Published: 2014
Online Access:http://www.scopus.com/inward/record.url?eid=2-s2.0-79953647359&partnerID=40&md5=e9020097d70205ab2a2fd77cfd3bb904
http://cmuir.cmu.ac.th/handle/6653943832/3788
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Chiang Mai University
Language: English